Advanced Biomed Inc. (ADVB) stock

ADVBNasdaqServices-Medical LaboratoriesFiscal year ends June 30

Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30

$2.53−0.78 (-23.56%)

Close on Nov 13, 2026Market cap $4.18MP/E 0.4Yield –

Advanced Biomed enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Advanced Biomed's enterprise value was $3.45M on Nov 11, 2026, against $6.43M a year earlier.

Period	Period end	Value	Change
2026	Nov 11, 2026	$3.45M	-5.8%
2025	Dec 31, 2025	$3.66M	–

Parsed from the XBRL in Advanced Biomed's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-20 reverse split on Feb 20, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is ADVB.

Operating margin-4883.8% · median -10789.2%

Net margin4759.5% · median -10260.0%

Advertisement
300 × 250

See a number that looks wrong?